Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Hypertension. 2022 Jan 4;79(3):588–598. doi: 10.1161/HYPERTENSIONAHA.121.18617

Figure 3.

Figure 3

Sensitivity analyses for effect of genetically-predicted body mass index (BMI), systolic blood pressure (SBP), low density lipoprotein cholesterol (LDL-C), type 2 diabetes (T2DM), smoking, urinary albumin-to-creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR) on the outcome of pre-eclampsia or eclampsia: Mendelian randomization Egger (MR-Egger), weighted median, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) estimates. Odds ratios and 95% confidence intervals (OR [95% CI]) are presented for every 1-SD increase genetically-predicted BMI, SBP, LDL-C, Smoking index, uACR and eGFR; and for every logOR increase in T2DM liability.